Napp Pharmaceuticals Limited
Richard Crook is an experienced Key Account Manager currently employed at Napp Pharmaceuticals Limited since November 2005, where consistent success in sales across therapeutic areas such as analgesia, respiratory, and diabetes has been demonstrated. Recognized as a runner-up in the Napp Account Manager of the Year awards in 2016 and 2017, Richard has a solid background in pharmaceutical sales, having held key account management positions at Novartis and sales representative roles at Organon and Daiichi Sankyo UK Ltd. Additionally, Richard began a career in project management at Lucas Automotive, where tenure lasted nearly two decades.
This person is not in any offices
Napp Pharmaceuticals Limited
Napp Pharmaceuticals is a member of the Mundipharma network of independent associated companies. Mundipharma is a global (ex-US) network of independent associated companies that research, develop and manufacture innovative pharmaceutical medicines and consumer healthcare products. We are an agile and fast-paced company seeking to increase access to health care through programmes and effective partnerships. We are forward-looking and dedicated to bringing innovative treatments to many of the world’s most challenging conditions and diseases including: Pain Management & Supportive Care, Consumer Health, Anti-Infectives, Biosimilars, CNS, Diabetes, Oncology, Ophthalmology, Respiratory and transplantation immunity. We make a difference to patient lives by delivering value to healthcare professionals in 120+ countries across Africa, Asia Pacific, Canada, Europe, Latin America and the Middle East. Our guiding principles, centred around Integrity and Patient-Centricity, are at the heart of everything we do. We encourage our people to think differently and our inclusive culture of continuous learning and collaboration make Mundipharma a great place to work.